Edition:
United States

Oasmia Pharmaceutical AB (OASM.ST)

OASM.ST on Stockholm Stock Exchange

3.91SEK
16 Feb 2018
Change (% chg)

-0.01kr (-0.25%)
Prev Close
3.92kr
Open
3.95kr
Day's High
3.96kr
Day's Low
3.80kr
Volume
187,956
Avg. Vol
623,194
52-wk High
7.29kr
52-wk Low
2.19kr

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Apr-18 1 30.00 30.00 30.00 --
Year Ending Apr-19 1 169.00 169.00 169.00 --
Earnings (per share)
Year Ending Apr-18 1 -0.53 -0.53 -0.53 --
Year Ending Apr-19 1 -0.32 -0.32 -0.32 --
Sales and Profit Figures in Swedish Krona (SEK);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 32.03 34.43
P/E High - Last 5 Yrs. -- 41.47 46.75
P/E Low - Last 5 Yrs. -- 23.35 24.14
Beta 0.72 0.81 0.81
Price to Sales (TTM) 394.42 6.26 8.57
Price to Book (MRQ) 1.76 4.27 5.14
Price to Tangible Book (MRQ) -- 4.76 6.30
Price to Cash Flow (TTM) -- 22.77 25.75
% Owned Institutions -- 1.27 2.33

Dividends

  Company industry sector
Dividend Yield -- 1.61 1.52
Dividend Yield - 5 Year Avg 0.00 2.15 2.01
Dividend 5 Year Growth Rate -- 4.26 5.27
Payout Ratio(TTM) -- 45.36 42.77

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 2,848.21 8.53 9.45
Sales (TTM) vs TTM 1 Yr. Ago -71.73 6.35 7.30
Sales - 5 Yr. Growth Rate -28.03 9.90 10.21
EPS (MRQ) vs Qtr. 1 Yr. Ago 62.12 16.64 20.15
EPS (TTM) vs TTM 1 Yr. Ago 16.30 -- --
EPS - 5 Yr. Growth Rate -- 10.39 11.48
Capital Spending - 5 Yr. Growth Rate -36.33 14.63 14.76

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 0.46 2.38 2.42
Current Ratio (MRQ) 0.54 3.33 3.38
LT Debt to Equity (MRQ) 0.00 8.98 11.85
Total Debt to Equity (MRQ) 35.21 12.06 15.12
Interest Coverage (TTM) -8.41 44.83 38.50

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 335.35 55.25 54.90
Gross Margin - 5 Yr. Avg. 1,178.88 52.61 52.64
EBITD Margin (TTM) -6,761.34 -- --
EBITD - 5 Yr. Avg -6,042.16 18.52 9.86
Operating Margin (TTM) -7,014.39 11.43 1.25
Operating Margin - 5 Yr. Avg. -6,306.29 14.30 5.07
Pre-Tax Margin (TTM) -7,926.10 11.82 2.12
Pre-Tax Margin - 5 Yr. Avg. -6,879.22 14.58 5.33
Net Profit Margin (TTM) -7,926.10 8.21 -1.38
Net Profit Margin - 5 Yr. Avg. -6,879.22 10.92 1.62
Effective Tax Rate (TTM) -- 22.39 22.03
Effective Tax Rate - 5 Yr. Avg. -- 23.57 24.20

Efficiency

  Company industry sector
Revenue/Employee (TTM) 26,530 919,747,049 819,569,446
Net Income/Employee (TTM) -2,102,818 107,578,762 95,804,981
Receivable Turnover (TTM) 0.50 5.29 5.40
Inventory Turnover (TTM) -0.29 2.59 3.48
Asset Turnover (TTM) 0.00 0.93 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -25.32 11.11 10.68
Return on Assets - 5 Yr. Avg. -25.00 12.64 12.00
Return on Investment (TTM) -39.97 14.00 13.54
Return on Investment - 5 Yr. Avg. -37.31 16.55 15.72
Return on Equity (TTM) -39.97 15.34 14.80
Return on Equity - 5 Yr. Avg. -37.54 17.61 16.91
  1 Year 3 Year 5 Year
Sales % -97.30 42.06 -28.03
EPS (TTM) % -1.95 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Oasmia Pharmaceutical AB

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 22.54 -- 99 52
13 Week 25.88 -- 99 42
26 Week 39.32 -- 99 18
52 Week -45.17 -- 16 28
YTD 49.43 -- 99 35
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 6.94%
# of Holders: 9
Total Shares Held: 12,242,033
3 Mo. Net Change: 10,366,243
# New Positions: 2
# Closed Positions: 0
# Increased Positions: 2
# Reduced Positions: 2
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.